Position in MDCX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$110,185
-$158,322 QoQ
Shares Held
289,055
+28.8% QoQ
Ownership
0.458%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $233,466,304 across 14 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
277,688 | $70,524,421 | |
| 2 | ABBV |
AbbVie Inc.
|
233,214 | $58,685,970 | |
| 3 | MRK |
Merck & Co., Inc.
|
266,566 | $34,253,731 | |
| 4 | AMGN |
Amgen Inc
|
55,311 | $20,029,219 | |
| 5 | PFE |
Pfizer Inc
|
744,034 | $17,916,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
194,227 | $11,191,359 | |
| 7 | AZN |
Astrazeneca PLC
|
30,398 | $5,764,068 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
43,759 | $5,528,512 |
All Filings in MDCX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 MDCXW | — | 49,000 | Shares | Sole | 2026-04-27 | |
| 2026-03-31 | $110,185 | 240,055 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 MDCXW | — | 49,000 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $268,507 | 175,495 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 MDCXW | — | 44,000 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $350,722 | 151,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 MDCXW | — | 39,000 | Shares | Sole | 2025-08-11 | |
| 2025-06-30 | $436,540 | 146,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 MDCXW | — | 15,000 | Shares | Sole | 2025-05-05 | |
| 2025-03-31 | $211,110 | 56,750 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||